glp-1 and stroke Efficacy of glucagon-like peptide-1 receptor agonists for prevention of among patients with without diabetes: A meta-analysis with the SELECT and FLOW trails Potential mechanisms of GLP-1-mediated neuroprotection
Description
Currently, subcutaneous delivery via needle-based syringes or pens is the common route of administration for GLP-1 receptor agonists
However, the underlying cellular/molecular mechanisms remain unclear
It sounds logical
GLP-1 medications are reshaping not only how people lose weight but also how they think about health, effort, and self-worth
